Weight-loss drugs could stop hormone replacement therapy from working and increase the associated risks, guidance has warned.

TIPPING the scales at more than 27st, Tomas Marks felt too fat and insecure to go on dates. The 25-year-old was too big to fit in restaurant booths, he was “constantly out of breath”, and he was ...

Weight loss jabs, eating no carbs, keto diet and simple calorie counting - there are a range of ways people can lose weight ...

A bizarre rumour claims Karan Johar secretly flew to South Korea multiple times to get his face insured, sparking wild online ...

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the ...

Omada is trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

The UK's MHRA have issued a warning to people on birth control who may also be taking drugs like Ozempic, Wegovy or Mounjaro ...

Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...